Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Debt Ratio data on record, last reported at 0.37 in Q3 2025.

  • For Q3 2025, Debt Ratio fell 5.27% year-over-year to 0.37; the TTM value through Sep 2025 reached 0.37, down 5.27%, while the annual FY2024 figure was 0.38, 2.17% down from the prior year.
  • Debt Ratio reached 0.37 in Q3 2025 per AMPH's latest filing, down from 0.38 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.41 in Q3 2023 and bottomed at 0.06 in Q2 2021.
  • Average Debt Ratio over 5 years is 0.25, with a median of 0.36 recorded in 2023.
  • Peak YoY movement for Debt Ratio: dropped 17.52% in 2021, then surged 296.95% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.11 in 2021, then decreased by 10.78% to 0.1 in 2022, then soared by 281.32% to 0.39 in 2023, then dropped by 2.17% to 0.38 in 2024, then dropped by 4.12% to 0.37 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.37 in Q3 2025, 0.38 in Q2 2025, and 0.37 in Q1 2025.